MDSS will support early-stage biomedical startups with direct investment, access to powerful Azure Cloud computing and opportunities to pilot their technologies in collaboration with discovery and clinical scientists at Merck
Growth of 75 percent would result in 6,300 jobs at cell and gene therapy companies and contract manufacturing organizations by 2025, with up to 25 percent of those jobs being in manufacturing roles requiring fewer educational requirements.
Fresh graduates and experienced professionals are welcome to join the Access Healthcare workforce supporting 100+ healthcare institutions and 500,000+ physicians.